Page 99 - Taiwan Food and Drug Administration 2016 Annual Report

2016 ANNUAL
REPORT

lessons could then be applied to the compilation of our pharmacopoeia and have it come up
to international standards.

Figure 2-8-9 1 Asia Lab-Net Workshop Figure 2-8-10 A member of the US Pharmacopoeia giving a speech Part II - Key Administrative Results International Cooperation and Cross-Strait Exchanges
st

3. Medical Devices
(1) In November 2015, TFDA visited the Massachusetts General Hospital (MGH) of Harvard
Medical School as well as Medtronic, a manufacturer of medical catheters (Figure 2-8-11) to
study and observe quality testing and veri?cation technologies employed for arti?cial joints,
thrombus extraction catheters, and other medical devices.
(2) TFDA visited manufacturers and companies such as Terumo Corporation, SHISEIDO Company,
Limited, BOKEN Quality Evaluation Institute, and Fujirebio Inc. in Japan during September
14 to 18, 2015 to study and observe measurement and veri?cation techniques employed for
intravenous administration sets, medical-grade hyaluronic acid, far infrared textiles, in vitro
diagnostic device (IVD), and other medical devices.

Figure 2-8-11 Visiting the MGH and Medtronic

Section 3. Cross-Strait Exchange

Current Status
After signing the Cross-Strait Food Safety Agreement on November 4, 2008, information
noti?cation and exchange systems were established between Taiwan and Mainland China. The
Expert Meeting of Cross-Strait Food Safety Competent Authorities and Cross-Strait Food Safety
Agreement - Meeting for the Safety of Food Imports and Exports were held every year to conduct
exchanges on food standards, risk communication, safety of food imports and exports, and other
relevant topics. 97